This Experimental Therapy Allegedly Cured Cancer Patient
A man participating in a trial of new experimental treatment has allegedly been cured of prostate cancer after being subjected to 22 cycles of the treatment.
The treatment, dubbed as bipolar androgen therapy or BAT, involves blasting off the patients with the sex hormone testosterone to shock the tumors, resulting to their death. One cycle of BAT is consisted of flooding the patient's body with testosterone and then being starved of it.
According to the report from Fox News, most of the 47 patients included in the study have lower levels of Prostate Specific Antigen, a blood maker used to monitor prostate cancer. Lowe levels of PSA may suggest that the tumor is shrinking and the progression of the cancer has slowed down.
"We think the results are unexpected and exciting," said Sam Denmeade, a Proffesor at John Hopkins University School of Medicine and lead author of the study, in a report from The Independent. "However, this is early stage research and further studies are needed in order to understand exactly how intriguing developments like this work and to test the findings more robustly in large clinical trials."
For 28 days, the participants received a high dose of testosterone, while being given drugs to stop the testicles from naturally producing the hormone.
The researchers observed that 30 percent of the participants have about 50 percent reduction in their PSA levels, while 40 percent of the men also experience dramatic decrease in their PSA levels.
Surprisingly, one of the participants has his PSA levels reduced to zero after three months and 22 cycles of the treatment. Zero PSA levels mean that the man has been cured from prostate cancer.
According to the Centers for Disease Control and Prevention, prostate cancer is one of the leading cancer deaths among men. In 2013, CDC tallied about 176,450 men living in the U.S. to be diagnosed with prostate cancer, with 27,681 who have died from the illness.